Question

I am a breastfeeding mother and i want to know if it is safe to use L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid? Is L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid safe for nursing mother and child? Does L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid extracts into breast milk? Does L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid has any long term or short term side effects on infants? Can L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid influence milk supply or can L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid decrease milk supply in lactating mothers?

L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid lactation summary

L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid usage has low risk in breastfeeding
  • DrLact safety Score for L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid is 3 out of 8 which is considered Low Risk as per our analyses.
  • A safety Score of 3 indicates that usage of L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid may cause some minor side effects in breastfed baby.
  • Our study of different scientific research indicates that L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid may cause moderate to no side effects in lactating mother.
  • Most of scientific studies and research papers declaring usage of L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • While using L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid usage in lactation

When associated to levodopa it may decrease breast milk production.

Alternate Drugs for Anti-parkinson drugs: Anticholinergics & Dopaminergic agents. ATC N04

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.